Singapore markets closed

Straits Times Index
3,293.13
+20.41(+0.62%)
S&P 500
5,070.55
+59.95(+1.20%)
Dow
38,503.69
+263.71(+0.69%)
Nasdaq
15,696.64
+245.33(+1.59%)
Bitcoin USD
66,348.12
+49.24(+0.07%)
CMC Crypto 200
1,433.13
+9.03(+0.63%)

GILD Jan 2025 35.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.2700

0.0000

(0.00%)

As of 12:17PM EDT. Market open.

Zacks
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
Zacks
Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Gilead (GILD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.